Raghuram Selvaraju
Stock Analyst at HC Wainwright & Co.
(1.97)
# 1,575
Out of 4,479 analysts
644
Total ratings
36.47%
Success rate
n/a
Average return
Main Sectors:
90 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GANX Gain Therapeutics | Maintains: Buy | $9 → $8 | $1.12 | +614.29% | 14 | Jul 2, 2024 | |
| URGN UroGen Pharma | Reiterates: Buy | $60 | $16.48 | +264.08% | 20 | Jul 1, 2024 | |
| GMAB Genmab | Reiterates: Buy | $50 | $24.85 | +101.21% | 34 | Jun 27, 2024 | |
| VRNA Verona Pharma | Maintains: Buy | $32 → $36 | $15.51 | +132.11% | 16 | Jun 27, 2024 | |
| RGLS Regulus Therapeutics | Maintains: Buy | $9 → $10 | $1.90 | +426.32% | 12 | Jun 25, 2024 | |
| BBIO BridgeBio Pharma | Reiterates: Buy | $43 | $25.20 | +70.63% | 10 | Jun 20, 2024 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $14 | $1.19 | +1,076.47% | 13 | Jun 20, 2024 | |
| OVID Ovid Therapeutics | Maintains: Buy | $9 → $3 | $0.86 | +247.95% | 3 | Jun 18, 2024 | |
| PYPD PolyPid | Reiterates: Buy | $14 | $4.24 | +230.19% | 4 | Jun 18, 2024 | |
| SCLX Scilex Holding Company | Reiterates: Buy | $7 | $1.88 | +272.34% | 6 | Jun 17, 2024 | |
| INDP Indaptus Therapeutics | Reiterates: Buy | $12 | $2.44 | +391.80% | 11 | Jun 17, 2024 | |
| PCSA Processa Pharmaceuticals | Reiterates: Buy | $8 | $2.09 | +282.78% | 3 | Jun 12, 2024 | |
| ANVS Annovis Bio | Reiterates: Buy | $23 | $5.27 | +336.43% | 13 | Jun 12, 2024 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Buy | $100 | $41.80 | +139.23% | 21 | Jun 11, 2024 | |
| ENLV Enlivex Therapeutics | Maintains: Buy | $7 → $6 | $1.38 | +334.78% | 10 | Jun 11, 2024 | |
| AVXL Anavex Life Sciences | Reiterates: Buy | $40 | $4.11 | +873.24% | 16 | Jun 11, 2024 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $190 | $81.03 | +134.48% | 20 | Jun 6, 2024 | |
| SPRB Spruce Biosciences | Reiterates: Neutral | n/a | $0.53 | - | 10 | Jun 5, 2024 | |
| EQ Equillium | Reiterates: Buy | $5 | $0.68 | +637.57% | 10 | Jun 5, 2024 | |
| AQST Aquestive Therapeutics | Reiterates: Buy | $9 | $2.45 | +267.35% | 16 | Jun 5, 2024 | |
| ENTX Entera Bio | Reiterates: Buy | $10 | $1.76 | +468.18% | 11 | Jun 5, 2024 | |
| BWAY BrainsWay | Reiterates: Buy | $15 | $5.86 | +155.97% | 15 | Jun 5, 2024 | |
| MBOT Microbot Medical | Reiterates: Buy | $7 | $1.01 | +593.07% | 6 | Jun 3, 2024 | |
| ONCT Oncternal Therapeutics | Reiterates: Buy | $19 | $7.02 | +170.85% | 11 | May 31, 2024 | |
| CGTX Cognition Therapeutics | Initiates: Buy | $10 | $1.67 | +498.80% | 1 | May 29, 2024 | |
| RKDA Arcadia Biosciences | Maintains: Buy | $10 → $6 | $3.10 | +93.55% | 11 | May 23, 2024 | |
| SLGL Sol-Gel Technologies | Reiterates: Buy | $6 | $0.86 | +597.67% | 15 | May 22, 2024 | |
| ORMP Oramed Pharmaceuticals | Reiterates: Neutral | n/a | $2.56 | - | 4 | May 20, 2024 | |
| LGVN Longeveron | Reiterates: Buy | $12 | $1.57 | +664.33% | 3 | May 17, 2024 | |
| FATE Fate Therapeutics | Maintains: Neutral | $7 → $5 | $3.26 | +53.37% | 3 | May 16, 2024 | |
| RMTI Rockwell Medical | Reiterates: Buy | $9 | $1.67 | +438.92% | 17 | May 16, 2024 | |
| SPRO Spero Therapeutics | Reiterates: Buy | $7 | $1.28 | +446.88% | 13 | May 16, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $18 → $15 | $6.27 | +139.23% | 9 | May 15, 2024 | |
| COCP Cocrystal Pharma | Reiterates: Buy | n/a | $2.40 | - | 13 | May 14, 2024 | |
| ADMA ADMA Biologics | Maintains: Buy | $7.5 → $10 | $11.55 | -13.42% | 13 | May 10, 2024 | |
| BTAI BioXcel Therapeutics | Reiterates: Buy | $10 | $1.17 | +754.70% | 30 | May 10, 2024 | |
| KZR Kezar Life Sciences | Reiterates: Buy | $20 | $0.58 | +3,327.00% | 12 | May 10, 2024 | |
| CDXC ChromaDex | Reiterates: Buy | $6 | $2.69 | +123.05% | 12 | May 9, 2024 | |
| BCPC Balchem | Maintains: Buy | $167 → $170 | $154.10 | +10.32% | 14 | May 6, 2024 | |
| CRDF Cardiff Oncology | Reiterates: Buy | $14 | $2.05 | +582.93% | 12 | May 6, 2024 | |
| RAPT RAPT Therapeutics | Reiterates: Neutral | n/a | $2.88 | - | 16 | Apr 10, 2024 | |
| HOTH Hoth Therapeutics | Reiterates: Buy | $4 | $0.92 | +336.97% | 2 | Apr 5, 2024 | |
| TRDA Entrada Therapeutics | Reiterates: Buy | $20 | $14.32 | +39.66% | 7 | Mar 18, 2024 | |
| ACRS Aclaris Therapeutics | Downgrades: Neutral | n/a | $1.15 | - | 11 | Jan 22, 2024 | |
| CING Cingulate | Maintains: Buy | $3.5 → $8 | $0.34 | +2,225.58% | 3 | Jan 5, 2024 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $10 | $3.40 | +194.12% | 9 | Dec 11, 2023 | |
| PXMD PaxMedica | Initiates: Buy | $3 | $0.21 | +1,328.57% | 1 | Dec 4, 2023 | |
| PLX Protalix BioTherapeutics | Reiterates: Buy | $10 | $1.17 | +754.70% | 4 | Nov 14, 2023 | |
| AEZS Aeterna Zentaris | Maintains: Buy | $112 → $60 | $4.70 | +1,176.60% | 10 | Nov 13, 2023 | |
| GLTO Galecto | Downgrades: Neutral | n/a | $0.47 | - | 5 | Sep 28, 2023 | |
| ENSC Ensysce Biosciences | Maintains: Buy | $9 → $7 | $0.50 | +1,300.56% | 2 | Sep 25, 2023 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Buy | $6 | $2.68 | +123.88% | 2 | Sep 25, 2023 | |
| GRTX Galera Therapeutics | Downgrades: Neutral | $6 → $0.3 | $0.13 | +140.00% | 6 | Aug 16, 2023 | |
| EVFM Evofem Biosciences | Maintains: Buy | $250 → $500 | $0.01 | +5,555,455.56% | 6 | Aug 15, 2022 | |
| ADXN Addex Therapeutics | Downgrades: Neutral | n/a | $7.84 | - | 4 | Jun 23, 2022 | |
| TYRA Tyra Biosciences | Initiates: Buy | $12 | $17.28 | -30.56% | 1 | Jun 23, 2022 | |
| NBSE NeuBase Therapeutics | Maintains: Buy | $300 → $200 | $0.38 | +52,810.05% | 3 | May 31, 2022 | |
| INM InMed Pharmaceuticals | Initiates: Buy | n/a | $0.25 | - | 1 | Nov 29, 2021 | |
| ABEO Abeona Therapeutics | Maintains: Buy | n/a | $4.20 | - | 3 | Nov 29, 2021 | |
| OMER Omeros | Maintains: Buy | n/a | $3.95 | - | 4 | Oct 19, 2021 | |
| SYBX Synlogic | Maintains: Buy | n/a | $1.49 | - | 2 | Oct 13, 2021 | |
| RDHL RedHill Biopharma | Maintains: Buy | n/a | $0.36 | - | 2 | Sep 15, 2021 | |
| IMUX Immunic | Maintains: Buy | n/a | $1.12 | - | 3 | Sep 7, 2021 | |
| XCUR Exicure | Maintains: Buy | n/a | $0.32 | - | 1 | May 17, 2021 | |
| RGEN Repligen | Maintains: Buy | n/a | $123.32 | - | 5 | May 5, 2021 | |
| BHC Bausch Health Companies | Maintains: Buy | n/a | $7.09 | - | 4 | Mar 16, 2021 | |
| TFFP TFF Pharmaceuticals | Maintains: Buy | $775 → $925 | $1.78 | +51,866.29% | 2 | Mar 5, 2021 | |
| NRBO NeuroBo Pharmaceuticals | Maintains: Buy | $4,800 → $3,840 | $4.54 | +84,481.50% | 2 | Feb 1, 2021 | |
| APDN Applied DNA Sciences | Maintains: Buy | $360 → $280 | $0.55 | +51,276.15% | 5 | Jan 14, 2021 | |
| CDNA CareDx | Maintains: Buy | n/a | $15.38 | - | 3 | Aug 5, 2020 | |
| CYDY CytoDyn | Downgrades: Neutral | n/a | $0.14 | - | 1 | Jul 6, 2020 | |
| REPL Replimune Group | Downgrades: Neutral | n/a | $9.36 | - | 1 | Jul 1, 2020 | |
| IGMS IGM Biosciences | Initiates: Buy | n/a | $6.79 | - | 1 | Jul 1, 2020 | |
| INO Inovio Pharmaceuticals | Downgrades: Neutral | n/a | $8.61 | - | 3 | Jun 29, 2020 | |
| EVOK Evoke Pharma | Upgrades: Buy | n/a | $0.47 | - | 2 | Jun 22, 2020 | |
| BLFS BioLife Solutions | Maintains: Buy | n/a | $20.79 | - | 1 | Mar 23, 2020 | |
| SWTX SpringWorks Therapeutics | Upgrades: Buy | n/a | $38.53 | - | 1 | Mar 19, 2020 | |
| CELC Celcuity | Initiates: Buy | n/a | $16.64 | - | 1 | Nov 20, 2018 | |
| CTMX CytomX Therapeutics | Initiates: Buy | n/a | $1.33 | - | 1 | Sep 13, 2018 | |
| KALA Kala Pharmaceuticals | Maintains: Buy | n/a | $6.89 | - | 1 | Aug 24, 2018 | |
| CRMD CorMedix | Maintains: Buy | n/a | $4.28 | - | 1 | May 23, 2018 | |
| CHEK Check-Cap | Maintains: Buy | n/a | $2.04 | - | 1 | May 23, 2018 | |
| TTOO T2 Biosystems | Maintains: Buy | $40,000 → $42,500 | $5.38 | +789,862.83% | 2 | Mar 29, 2018 | |
| DRRX DURECT | Upgrades: Buy | n/a | $1.31 | - | 3 | Mar 6, 2018 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | n/a | $24.63 | - | 3 | Mar 5, 2018 | |
| AEMD Aethlon Medical | Initiates: Buy | n/a | $0.45 | - | 1 | Nov 20, 2017 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $18,000 → $6,000 | $1.94 | +309,178.35% | 1 | Nov 13, 2017 | |
| IMRN Immuron | Initiates: Buy | n/a | $2.26 | - | 1 | Oct 18, 2017 | |
| OCUL Ocular Therapeutix | Initiates: Buy | n/a | $6.66 | - | 1 | Jul 26, 2017 | |
| ALIM Alimera Sciences | Initiates: Buy | n/a | $5.52 | - | 1 | Apr 27, 2017 |
Gain Therapeutics
Jul 2, 2024
Maintains: Buy
Price Target: $9 → $8
Current: $1.12
Upside: +614.29%
UroGen Pharma
Jul 1, 2024
Reiterates: Buy
Price Target: $60
Current: $16.48
Upside: +264.08%
Genmab
Jun 27, 2024
Reiterates: Buy
Price Target: $50
Current: $24.85
Upside: +101.21%
Verona Pharma
Jun 27, 2024
Maintains: Buy
Price Target: $32 → $36
Current: $15.51
Upside: +132.11%
Regulus Therapeutics
Jun 25, 2024
Maintains: Buy
Price Target: $9 → $10
Current: $1.90
Upside: +426.32%
BridgeBio Pharma
Jun 20, 2024
Reiterates: Buy
Price Target: $43
Current: $25.20
Upside: +70.63%
Reviva Pharmaceuticals Holdings
Jun 20, 2024
Reiterates: Buy
Price Target: $14
Current: $1.19
Upside: +1,076.47%
Ovid Therapeutics
Jun 18, 2024
Maintains: Buy
Price Target: $9 → $3
Current: $0.86
Upside: +247.95%
PolyPid
Jun 18, 2024
Reiterates: Buy
Price Target: $14
Current: $4.24
Upside: +230.19%
Scilex Holding Company
Jun 17, 2024
Reiterates: Buy
Price Target: $7
Current: $1.88
Upside: +272.34%
Indaptus Therapeutics
Jun 17, 2024
Reiterates: Buy
Price Target: $12
Current: $2.44
Upside: +391.80%
Processa Pharmaceuticals
Jun 12, 2024
Reiterates: Buy
Price Target: $8
Current: $2.09
Upside: +282.78%
Annovis Bio
Jun 12, 2024
Reiterates: Buy
Price Target: $23
Current: $5.27
Upside: +336.43%
MoonLake Immunotherapeutics
Jun 11, 2024
Reiterates: Buy
Price Target: $100
Current: $41.80
Upside: +139.23%
Enlivex Therapeutics
Jun 11, 2024
Maintains: Buy
Price Target: $7 → $6
Current: $1.38
Upside: +334.78%
Anavex Life Sciences
Jun 11, 2024
Reiterates: Buy
Price Target: $40
Current: $4.11
Upside: +873.24%
Axsome Therapeutics
Jun 6, 2024
Reiterates: Buy
Price Target: $190
Current: $81.03
Upside: +134.48%
Spruce Biosciences
Jun 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.53
Upside: -
Equillium
Jun 5, 2024
Reiterates: Buy
Price Target: $5
Current: $0.68
Upside: +637.57%
Aquestive Therapeutics
Jun 5, 2024
Reiterates: Buy
Price Target: $9
Current: $2.45
Upside: +267.35%
Entera Bio
Jun 5, 2024
Reiterates: Buy
Price Target: $10
Current: $1.76
Upside: +468.18%
BrainsWay
Jun 5, 2024
Reiterates: Buy
Price Target: $15
Current: $5.86
Upside: +155.97%
Microbot Medical
Jun 3, 2024
Reiterates: Buy
Price Target: $7
Current: $1.01
Upside: +593.07%
Oncternal Therapeutics
May 31, 2024
Reiterates: Buy
Price Target: $19
Current: $7.02
Upside: +170.85%
Cognition Therapeutics
May 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.67
Upside: +498.80%
Arcadia Biosciences
May 23, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $3.10
Upside: +93.55%
Sol-Gel Technologies
May 22, 2024
Reiterates: Buy
Price Target: $6
Current: $0.86
Upside: +597.67%
Oramed Pharmaceuticals
May 20, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.56
Upside: -
Longeveron
May 17, 2024
Reiterates: Buy
Price Target: $12
Current: $1.57
Upside: +664.33%
Fate Therapeutics
May 16, 2024
Maintains: Neutral
Price Target: $7 → $5
Current: $3.26
Upside: +53.37%
Rockwell Medical
May 16, 2024
Reiterates: Buy
Price Target: $9
Current: $1.67
Upside: +438.92%
Spero Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $7
Current: $1.28
Upside: +446.88%
Fennec Pharmaceuticals
May 15, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $6.27
Upside: +139.23%
Cocrystal Pharma
May 14, 2024
Reiterates: Buy
Price Target: n/a
Current: $2.40
Upside: -
ADMA Biologics
May 10, 2024
Maintains: Buy
Price Target: $7.5 → $10
Current: $11.55
Upside: -13.42%
BioXcel Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $10
Current: $1.17
Upside: +754.70%
Kezar Life Sciences
May 10, 2024
Reiterates: Buy
Price Target: $20
Current: $0.58
Upside: +3,327.00%
ChromaDex
May 9, 2024
Reiterates: Buy
Price Target: $6
Current: $2.69
Upside: +123.05%
Balchem
May 6, 2024
Maintains: Buy
Price Target: $167 → $170
Current: $154.10
Upside: +10.32%
Cardiff Oncology
May 6, 2024
Reiterates: Buy
Price Target: $14
Current: $2.05
Upside: +582.93%
RAPT Therapeutics
Apr 10, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.88
Upside: -
Hoth Therapeutics
Apr 5, 2024
Reiterates: Buy
Price Target: $4
Current: $0.92
Upside: +336.97%
Entrada Therapeutics
Mar 18, 2024
Reiterates: Buy
Price Target: $20
Current: $14.32
Upside: +39.66%
Aclaris Therapeutics
Jan 22, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
Cingulate
Jan 5, 2024
Maintains: Buy
Price Target: $3.5 → $8
Current: $0.34
Upside: +2,225.58%
Eton Pharmaceuticals
Dec 11, 2023
Reiterates: Buy
Price Target: $10
Current: $3.40
Upside: +194.12%
PaxMedica
Dec 4, 2023
Initiates: Buy
Price Target: $3
Current: $0.21
Upside: +1,328.57%
Protalix BioTherapeutics
Nov 14, 2023
Reiterates: Buy
Price Target: $10
Current: $1.17
Upside: +754.70%
Aeterna Zentaris
Nov 13, 2023
Maintains: Buy
Price Target: $112 → $60
Current: $4.70
Upside: +1,176.60%
Galecto
Sep 28, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.47
Upside: -
Ensysce Biosciences
Sep 25, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $0.50
Upside: +1,300.56%
Anebulo Pharmaceuticals
Sep 25, 2023
Reiterates: Buy
Price Target: $6
Current: $2.68
Upside: +123.88%
Galera Therapeutics
Aug 16, 2023
Downgrades: Neutral
Price Target: $6 → $0.3
Current: $0.13
Upside: +140.00%
Evofem Biosciences
Aug 15, 2022
Maintains: Buy
Price Target: $250 → $500
Current: $0.01
Upside: +5,555,455.56%
Addex Therapeutics
Jun 23, 2022
Downgrades: Neutral
Price Target: n/a
Current: $7.84
Upside: -
Tyra Biosciences
Jun 23, 2022
Initiates: Buy
Price Target: $12
Current: $17.28
Upside: -30.56%
NeuBase Therapeutics
May 31, 2022
Maintains: Buy
Price Target: $300 → $200
Current: $0.38
Upside: +52,810.05%
InMed Pharmaceuticals
Nov 29, 2021
Initiates: Buy
Price Target: n/a
Current: $0.25
Upside: -
Abeona Therapeutics
Nov 29, 2021
Maintains: Buy
Price Target: n/a
Current: $4.20
Upside: -
Omeros
Oct 19, 2021
Maintains: Buy
Price Target: n/a
Current: $3.95
Upside: -
Synlogic
Oct 13, 2021
Maintains: Buy
Price Target: n/a
Current: $1.49
Upside: -
RedHill Biopharma
Sep 15, 2021
Maintains: Buy
Price Target: n/a
Current: $0.36
Upside: -
Immunic
Sep 7, 2021
Maintains: Buy
Price Target: n/a
Current: $1.12
Upside: -
Exicure
May 17, 2021
Maintains: Buy
Price Target: n/a
Current: $0.32
Upside: -
Repligen
May 5, 2021
Maintains: Buy
Price Target: n/a
Current: $123.32
Upside: -
Bausch Health Companies
Mar 16, 2021
Maintains: Buy
Price Target: n/a
Current: $7.09
Upside: -
TFF Pharmaceuticals
Mar 5, 2021
Maintains: Buy
Price Target: $775 → $925
Current: $1.78
Upside: +51,866.29%
NeuroBo Pharmaceuticals
Feb 1, 2021
Maintains: Buy
Price Target: $4,800 → $3,840
Current: $4.54
Upside: +84,481.50%
Applied DNA Sciences
Jan 14, 2021
Maintains: Buy
Price Target: $360 → $280
Current: $0.55
Upside: +51,276.15%
CareDx
Aug 5, 2020
Maintains: Buy
Price Target: n/a
Current: $15.38
Upside: -
CytoDyn
Jul 6, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.14
Upside: -
Replimune Group
Jul 1, 2020
Downgrades: Neutral
Price Target: n/a
Current: $9.36
Upside: -
IGM Biosciences
Jul 1, 2020
Initiates: Buy
Price Target: n/a
Current: $6.79
Upside: -
Inovio Pharmaceuticals
Jun 29, 2020
Downgrades: Neutral
Price Target: n/a
Current: $8.61
Upside: -
Evoke Pharma
Jun 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.47
Upside: -
BioLife Solutions
Mar 23, 2020
Maintains: Buy
Price Target: n/a
Current: $20.79
Upside: -
SpringWorks Therapeutics
Mar 19, 2020
Upgrades: Buy
Price Target: n/a
Current: $38.53
Upside: -
Celcuity
Nov 20, 2018
Initiates: Buy
Price Target: n/a
Current: $16.64
Upside: -
CytomX Therapeutics
Sep 13, 2018
Initiates: Buy
Price Target: n/a
Current: $1.33
Upside: -
Kala Pharmaceuticals
Aug 24, 2018
Maintains: Buy
Price Target: n/a
Current: $6.89
Upside: -
CorMedix
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $4.28
Upside: -
Check-Cap
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $2.04
Upside: -
T2 Biosystems
Mar 29, 2018
Maintains: Buy
Price Target: $40,000 → $42,500
Current: $5.38
Upside: +789,862.83%
DURECT
Mar 6, 2018
Upgrades: Buy
Price Target: n/a
Current: $1.31
Upside: -
DENTSPLY SIRONA
Mar 5, 2018
Maintains: Neutral
Price Target: n/a
Current: $24.63
Upside: -
Aethlon Medical
Nov 20, 2017
Initiates: Buy
Price Target: n/a
Current: $0.45
Upside: -
Bio-Path Holdings
Nov 13, 2017
Maintains: Buy
Price Target: $18,000 → $6,000
Current: $1.94
Upside: +309,178.35%
Immuron
Oct 18, 2017
Initiates: Buy
Price Target: n/a
Current: $2.26
Upside: -
Ocular Therapeutix
Jul 26, 2017
Initiates: Buy
Price Target: n/a
Current: $6.66
Upside: -
Alimera Sciences
Apr 27, 2017
Initiates: Buy
Price Target: n/a
Current: $5.52
Upside: -